Slingshot members are tracking this event:
Novartis' (NVS) Dual Combination Bronchodilator Inhalation Powder for Treatment of Airflow Obstruction in Patients with Chronic Pulmonary Disease Approved by FDA
Slingshot Insights Explained
Oct 29, 2015
Don’t see a project related to the catalyst you care about?
Related Keywords Utibron Neohaler, Chronic Bronchitis, Emphysema, Chronic Obstructive Pulmonary Disease, Cop